Entities / Company
Morphosys.
German biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 18
What's happening
Gone quiet
No new reports in 90+ days-
Idorsia appoints Roland Wandeler as CEO, who previously held senior roles at Morphosys and Amgen.Some support3 reports
-
Novartis acquired MorphoSys for $2.9B. Barbara Krebs-Pohl joined the CASI Board of Directors and previously served as CBO at MorphoSys.Some support2 reports1 development inside
-
Antibe Therapeutics and Morphosys are both companies operating in the pharmaceutical development sector.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Morphosys this week
News at the entities that move Morphosys most-
Novartis StructuralNovartis developed a Bruton's tyrosine kinase inhibitor, with Heinz Wiendl being a professor at the University of Freiburg.Moves Morphosys
-
Eli Lilly and Company OperationalEli Lilly and Company developed the drug Retatrutide.Moves Morphosys
Connections
The 3 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Novartis Structural
Novartis acquired Morphosys, establishing it as a subsidiary, and the two entities maintain ongoing collaboration agreements.
-
Eli Lilly and Company Operational
The two companies maintain active collaboration agreements regarding their business operations.
-
Antibe Therapeutics Operational
Both companies are active competitors operating in the specialized pharmaceutical development and biotech sectors.